Follistim AQ 350 [iU]/.42mL

Follistim AQ 350 [iU]/.42mL is a subcutaneous injection solution containing follitropin, a fertility medication used to stimulate ovarian follicle development. This product is manufactured by Merck Sharp & Dohme LLC in the USA.

Follistim AQ 350 [iU]/.42mL is primarily used in assisted reproductive technologies to stimulate the ovaries to produce multiple follicles. It is often part of protocols for in vitro fertilization (IVF) or other fertility treatments. The active ingredient, follitropin, is a form of follicle-stimulating hormone (FSH) that plays a crucial role in the development of eggs in the ovaries.

When used as directed, Follistim AQ 350 [iU]/.42mL may help stimulate the growth of ovarian follicles, which can be essential for fertility treatments. Some users may experience side effects such as injection site reactions, headaches, or abdominal discomfort. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Follistim AQ 350 [iU]/.42mL should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always check the packaging for any specific storage instructions and ensure the solution is clear and free from particles before use.

Follistim AQ 350 [iU]/.42mL may interact with other medications, particularly those that affect hormone levels or the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy or safety of this medication.